COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

PCCA Blog - 2018 - Azelastine - Main Image 01.png

We’re excited that patients and physicians now have access to Azelastine Hydrochloride USP as an ingredient option in compounded medications. There are some commercial products available, including a combination product, but when those items don’t fit the specific needs of patients, we need to put on our thinking caps and start looking for other options for them. We’re sure that you compounders out there can come up with a few of your own as well.

PCCA Blog - 2018 - PCCA Science Update - Main Image 01.png

By Maria Carvalho, PharmD, MRPharmS, PhD. She is the Manager of PCCA Science.

PCCA Blog - 2018 Opioid Epidemic - Main Image.png

Pain affects more Americans than diabetes, heart disease and cancer combined. It represents an important public health issue that is associated with a wide range of injury and disease. As a result, an estimated 20% of patients with chronic pain receive an opioid prescription when visiting physician offices, and rates of opioid prescribing have grown significantly, in particular for family practice, general practice and internal medicine.

PCCA Blog - Compounding Kiki Vote - Image.png

Vote for Your Favorite Compounding Kiki Challenge Video

Welcome to our blog. This will be a place for anyone involved in the pharmacy compounding industry to engage with shareable content that affects compounders, health care practitioners and patients.